Due to its importance for fluid secretion in airways submucosal glands, AQP5 has been suggested to be a pharmacological target to treat the hyper-viscous and excessive gland secretions in cystic fibrosis and bronchitis/rhinitis, respectively. This evidence concerns the gene AQP5 and rhinitis.